INR 552.6
(3.05%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 771.68 Million INR | 10.2% |
2022 | 700.27 Million INR | -3.73% |
2021 | 727.42 Million INR | 56.06% |
2020 | 466.12 Million INR | 28.67% |
2019 | 362.25 Million INR | -0.0% |
2018 | 362.25 Million INR | -20.23% |
2017 | 454.11 Million INR | 21.73% |
2016 | 373.06 Million INR | 35.75% |
2015 | 274.81 Million INR | 25.96% |
2014 | 218.18 Million INR | -8.48% |
2013 | 238.41 Million INR | 23.36% |
2012 | 193.27 Million INR | -9.71% |
2011 | 214.06 Million INR | -17.88% |
2010 | 260.67 Million INR | 13.48% |
2009 | 229.7 Million INR | 60.47% |
2008 | 143.14 Million INR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 Q3 | - INR | -100.0% |
2023 Q1 | - INR | -100.0% |
2023 FY | 771.68 Million INR | 10.2% |
2023 Q4 | 771.68 Million INR | 0.0% |
2023 Q2 | 655.86 Million INR | 0.0% |
2022 Q4 | 700.27 Million INR | 0.0% |
2022 FY | 700.27 Million INR | -3.73% |
2022 Q2 | 787.56 Million INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 Q1 | - INR | -100.0% |
2021 Q4 | 727.42 Million INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 FY | 727.42 Million INR | 56.06% |
2021 Q2 | 488.02 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2020 FY | 466.12 Million INR | 28.67% |
2020 Q3 | - INR | -100.0% |
2020 Q4 | 466.12 Million INR | 0.0% |
2020 Q1 | - INR | -100.0% |
2020 Q2 | 403.73 Million INR | 0.0% |
2019 Q3 | - INR | -100.0% |
2019 Q1 | - INR | -100.0% |
2019 Q2 | 375.71 Million INR | 0.0% |
2019 Q4 | 362.25 Million INR | 0.0% |
2019 FY | 362.25 Million INR | -0.0% |
2018 Q3 | - INR | -100.0% |
2018 Q2 | 340.33 Million INR | 0.0% |
2018 Q1 | - INR | -100.0% |
2018 FY | 362.25 Million INR | -20.23% |
2018 Q4 | 362.25 Million INR | 0.0% |
2017 FY | 454.11 Million INR | 21.73% |
2017 Q3 | - INR | -100.0% |
2017 Q1 | - INR | -100.0% |
2017 Q4 | 454.11 Million INR | 0.0% |
2017 Q2 | 324.58 Million INR | 0.0% |
2016 Q3 | - INR | -100.0% |
2016 FY | 373.06 Million INR | 35.75% |
2016 Q4 | 373.06 Million INR | 0.0% |
2016 Q2 | 291.98 Million INR | 0.0% |
2016 Q1 | - INR | -100.0% |
2015 FY | 274.81 Million INR | 25.96% |
2015 Q3 | - INR | -100.0% |
2015 Q2 | 281.57 Million INR | 0.0% |
2015 Q4 | 274.81 Million INR | 0.0% |
2015 Q1 | - INR | -100.0% |
2014 Q1 | - INR | -100.0% |
2014 Q4 | 218.18 Million INR | 0.0% |
2014 Q3 | - INR | -100.0% |
2014 FY | 218.18 Million INR | -8.48% |
2014 Q2 | 284.35 Million INR | 0.0% |
2013 FY | 238.41 Million INR | 23.36% |
2013 Q3 | - INR | -100.0% |
2013 Q4 | 238.41 Million INR | 0.0% |
2013 Q1 | - INR | -100.0% |
2013 Q2 | 237.94 Million INR | 0.0% |
2012 Q4 | 193.27 Million INR | 0.0% |
2012 Q2 | 216.32 Million INR | 0.0% |
2012 Q3 | - INR | -100.0% |
2012 FY | 193.27 Million INR | -9.71% |
2011 Q4 | 214.06 Million INR | 0.0% |
2011 FY | 214.06 Million INR | -17.88% |
2010 FY | 260.67 Million INR | 13.48% |
2009 FY | 229.7 Million INR | 60.47% |
2008 FY | 143.14 Million INR | 0.0% |
2008 Q4 | 143.14 Million INR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 16.43 Billion INR | 95.305% |
Hester Biosciences Limited | 755.81 Million INR | -2.1% |
Aarti Drugs Limited | 4.85 Billion INR | 84.118% |
Aarti Pharmalabs Limited | 6.42 Billion INR | 87.996% |
Albert David Limited | 436.12 Million INR | -76.942% |
Alembic Limited | 113.4 Million INR | -580.495% |
Alkem Laboratories Limited | 26.61 Billion INR | 97.1% |
Bafna Pharmaceuticals Limited | 296.41 Million INR | -160.335% |
Bajaj HealthCare Limited | 1.44 Billion INR | 46.425% |
Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -2926.556% |
Brooks Laboratories Limited | 96.1 Million INR | -702.931% |
Eris Lifesciences Limited | 1.89 Billion INR | 59.177% |
FDC Limited | 3.88 Billion INR | 80.157% |
Glenmark Life Sciences Limited | 6.66 Billion INR | 88.423% |
Gufic Biosciences Limited | 2 Billion INR | 61.509% |
Hikal Limited | 3.03 Billion INR | 74.592% |
Ind-Swift Limited | 640.91 Million INR | -20.403% |
Innova Captab Limited | 1.44 Billion INR | 46.417% |
IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 81.836% |
Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -414.557% |
Jubilant Pharmova Limited | 12.89 Billion INR | 94.016% |
Lupin Limited | 49.53 Billion INR | 98.442% |
Mangalam Drugs & Organics Limited | 1.23 Billion INR | 37.586% |
Medico Remedies Limited | 163.37 Million INR | -372.346% |
Morepen Laboratories Limited | 2.48 Billion INR | 68.958% |
Nectar Lifesciences Limited | 7.09 Billion INR | 89.118% |
Orchid Pharma Limited | 2.64 Billion INR | 70.795% |
Procter & Gamble Health Limited | 1.09 Billion INR | 29.275% |
RPG Life Sciences Limited | 1.01 Billion INR | 23.596% |
Kilitch Drugs (India) Limited | 39.88 Million INR | -1835.008% |
Sigachi Industries Limited | 707.2 Million INR | -9.117% |
Solara Active Pharma Sciences Limited | 3.59 Billion INR | 78.547% |
Suven Pharmaceuticals Limited | 2.31 Billion INR | 66.622% |
Themis Medicare Limited | 705.74 Million INR | -9.343% |
Unichem Laboratories Limited | 7.04 Billion INR | 89.049% |
Vaishali Pharma Limited | 3.79 Million INR | -20223.44% |
Wanbury Limited | 360.23 Million INR | -114.218% |
Windlas Biotech Limited | 621.89 Million INR | -24.086% |
ZIM Laboratories Limited | 812.62 Million INR | 5.039% |
Ind-Swift Laboratories Limited | 104.57 Million INR | -637.907% |
Ipca Laboratories Limited | 24.71 Billion INR | 96.877% |
Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.218% |
Venus Remedies Limited | 1.21 Billion INR | 36.586% |
Sakar Healthcare Limited | 277.32 Million INR | -178.261% |
Aurobindo Pharma Limited | 98.08 Billion INR | 99.213% |
Divi's Laboratories Limited | 31.84 Billion INR | 97.576% |
AstraZeneca Pharma India Limited | 2.27 Billion INR | 66.137% |
Mankind Pharma Limited | 15.53 Billion INR | 95.033% |
Sequent Scientific Limited | 3.46 Billion INR | 77.712% |
Laurus Labs Limited | 18.45 Billion INR | 95.818% |
Neuland Laboratories Limited | 3.5 Billion INR | 77.979% |
J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 84.643% |
Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 96.929% |
Zydus Lifesciences Limited | 34.41 Billion INR | 97.758% |
Amrutanjan Health Care Limited | 289.04 Million INR | -166.974% |
Wockhardt Limited | 6.4 Billion INR | 87.942% |
Bal Pharma Limited | 878.11 Million INR | 12.121% |
Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 98.786% |
Bliss GVS Pharma Limited | 1.18 Billion INR | 34.85% |
Par Drugs and Chemicals Limited | 41.77 Million INR | -1747.453% |
Caplin Point Laboratories Limited | 3.63 Billion INR | 78.744% |
Shilpa Medicare Limited | 3.44 Billion INR | 77.628% |
Valiant Laboratories Limited | 100.15 Million INR | -670.494% |
Ajanta Pharma Limited | 8.28 Billion INR | 90.684% |
Aarey Drugs & Pharmaceuticals Limited | 346.75 Million INR | -122.542% |
Granules India Limited | 13 Billion INR | 94.066% |
Medicamen Biotech Limited | 593.75 Million INR | -29.967% |
Syncom Formulations (India) Limited | 210.81 Million INR | -266.047% |
Piramal Enterprises Limited | - INR | -Infinity% |
Torrent Pharmaceuticals Limited | 22.79 Billion INR | 96.614% |
NATCO Pharma Limited | 7 Billion INR | 88.984% |
Suven Life Sciences Limited | 7.08 Million INR | -10791.757% |
Krebs Biochemicals & Industries Limited | 97.96 Million INR | -687.719% |
Strides Pharma Science Limited | 11.26 Billion INR | 93.148% |
Indoco Remedies Limited | 3.53 Billion INR | 78.143% |
Alpa Laboratories Limited | 136.65 Million INR | -464.701% |
Lasa Supergenerics Limited | 190.43 Million INR | -305.222% |
Sun Pharma Advanced Research Company Limited | 14.79 Million INR | -5116.881% |